$156.53
+3.49
(+2.28%)
As of Oct 15, 2026, 12:32 AM EDT
Price history
Today's analyst average
Analyst average over timeIndividual analyst targets
Analyst history starts Jul 16, 2026, the first target we tracked for PG.
Procter & Gamble (PG) is trading up at $156.53 (+2.28%) on NYSE/NASDAQ, as of the latest quote. It is a S&P 500 constituent in the Consumer Staples sector.
Analyst price targets on PG
Current price targets from 4 firms average $166, median $166, ranging from $162 to $170 — the average is 6% above the current $157. Each is tracked to its date and scored the same way a member's call is.
- RBC Capital Markets $148 → $166 by Oct 2027 Oct 6, 2026 via MarketBeat · RBC Capital Markets's track record
- Evercore ISI $150 → $166 by Oct 2027 Oct 6, 2026 via Investing.com · Evercore ISI's track record
- Citi $144 → $170 by Jul 2027 Jul 30, 2026 via MarketBeat · Citi's track record
- JPMorgan $152 → $162 by Jul 2027 Jul 16, 2026 via MarketBeat · JPMorgan's track record
Targets published by research firms, extracted from the news, checked against independent reporting, and linked to their source. Where a firm did not state a horizon the target is tracked as 12 months, the industry convention; the rows where the firm set its own horizon are marked. Reported here as facts about what was published — not recommendations from Dalsna Finance, and no firm listed is affiliated with this site.
Procter & Gamble revenue & net income history (FY2017–FY2026)
RevenueNet incomeNet margin (right axis, %)
| FY2017Jun 2017 | FY2018Jun 2018 | FY2019Jun 2019 | FY2020Jun 2020 | FY2021Jun 2021 | FY2022Jun 2022 | FY2023Jun 2023 | FY2024Jun 2024 | FY2025Jun 2025 | FY2026Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $65.1B | $66.8B | $67.7B | $71.0B | $76.1B | $80.2B | $82.0B | $84.0B | $84.3B | $87.0B |
| Growth (year over year) | −0.4% | +2.7% | +1.3% | +4.8% | +7.3% | +5.3% | +2.3% | +2.5% | +0.3% | +3.3% |
| Gross profit | $32.4B | $32.4B | $32.9B | $35.7B | $39.0B | $38.0B | $39.2B | $43.2B | $43.1B | $43.7B |
| Gross margin | 49.8% | 48.5% | 48.6% | 50.3% | 51.2% | 47.4% | 47.9% | 51.4% | 51.2% | 50.2% |
| Operating income | $13.8B | $13.4B | $5.49B | $15.7B | $18.0B | $17.8B | $18.1B | $18.5B | $20.5B | $19.7B |
| Operating margin | 21.2% | 20.0% | 8.1% | 22.1% | 23.6% | 22.2% | 22.1% | 22.1% | 24.3% | 22.7% |
| Net income | $15.3B | $9.75B | $3.90B | $13.0B | $14.3B | $14.7B | $14.7B | $14.9B | $16.0B | $16.0B |
| Net margin | 23.6% | 14.6% | 5.8% | 18.4% | 18.8% | 18.4% | 17.9% | 17.7% | 19.0% | 18.4% |
| EPS (diluted) | $5.59 | $3.67 | $1.43 | $4.96 | $5.50 | $5.81 | $5.90 | $6.02 | $6.51 | $6.62 |
| Balance sheet | ||||||||||
| Cash and equivalents | $5.57B | $2.57B | $4.24B | $16.2B | $10.3B | $7.21B | $8.25B | $9.48B | $9.56B | $9.94B |
| Total assets | $120.4B | $118.3B | $115.1B | $120.7B | $119.3B | $117.2B | $120.8B | $122.4B | $125.2B | $126.5B |
| Total liabilities | $64.6B | $65.4B | $67.5B | $73.8B | $72.7B | $70.4B | $73.8B | $71.8B | $72.9B | $72.2B |
| Long-term debt | $18.0B | $20.9B | $20.4B | $23.5B | $23.1B | $22.8B | $24.4B | $25.3B | $25.0B | $22.8B |
| Shareholders' equity | $55.8B | $52.9B | $47.6B | $46.9B | $46.7B | $46.9B | $47.1B | $50.6B | $52.3B | $54.3B |
| Cash flow | ||||||||||
| Operating cash flow | $12.8B | $14.9B | $15.2B | $17.4B | $18.4B | $16.7B | $16.8B | $19.8B | $17.8B | $19.6B |
| Capital expenditure | $3.38B | $3.72B | $3.35B | $3.07B | $2.79B | $3.16B | $3.06B | $3.32B | $3.77B | $4.41B |
| Free cash flow | $9.37B | $11.2B | $11.9B | $14.3B | $15.6B | $13.6B | $13.8B | $16.5B | $14.0B | $15.1B |
| Dividends paid | $7.24B | $7.31B | $7.50B | $7.79B | $8.26B | $8.77B | $9.00B | $9.31B | $9.87B | $10.2B |
| Share buybacks | $5.20B | $7.00B | $5.00B | $7.41B | $11.0B | $10.0B | $7.35B | $5.01B | $6.50B | $5.03B |
RevenueNet incomeNet margin (right axis, %)
| Q1 FY25Sep 2024 | Q2 FY25Dec 2024 | Q3 FY25Mar 2025 | Q4 FY25†Jun 2025 | Q1 FY26Sep 2025 | Q2 FY26Dec 2025 | Q3 FY26Mar 2026 | Q4 FY26†Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $21.7B | $21.9B | $19.8B | $20.9B | $22.4B | $22.2B | $21.2B | $21.2B |
| Growth (year over year) | −0.6% | +2.1% | −2.1% | +1.7% | +3.0% | +1.5% | +7.4% | +1.5% |
| Gross profit | $11.3B | $11.5B | $10.1B | $10.3B | $11.5B | $11.4B | $10.5B | $10.3B |
| Gross margin | 52.1% | 52.4% | 51.0% | 49.1% | 51.4% | 51.2% | 49.5% | 48.5% |
| Operating income | $5.80B | $5.74B | $4.56B | $4.36B | $5.86B | $5.37B | $4.58B | $3.95B |
| Operating margin | 26.7% | 26.2% | 23.0% | 20.8% | 26.2% | 24.2% | 21.5% | 18.6% |
| Net income | $3.96B | $4.63B | $3.77B | $3.62B | $4.75B | $4.32B | $3.93B | $3.04B |
| Net margin | 18.2% | 21.2% | 19.1% | 17.3% | 21.2% | 19.4% | 18.5% | 14.4% |
| EPS (diluted) | $1.61 | $1.88 | $1.54 | $1.48 | $1.95 | $1.78 | $1.63 | $1.26 |
| Balance sheet | ||||||||
| Cash and equivalents | $12.2B | $10.2B | $9.12B | $9.56B | $11.2B | $10.8B | $12.3B | $9.94B |
| Total assets | $126.5B | $122.6B | $123.0B | $125.2B | $127.6B | $127.3B | $128.4B | $126.5B |
| Total liabilities | $74.3B | $71.2B | $70.4B | $72.9B | $74.0B | $74.0B | $73.6B | $72.2B |
| Long-term debt | $25.7B | $25.3B | $24.3B | $25.0B | $24.3B | $25.6B | $23.9B | $22.8B |
| Shareholders' equity | $52.1B | $51.4B | $52.5B | $52.3B | $53.6B | $53.3B | $54.7B | $54.3B |
| Cash flow | ||||||||
| Operating cash flow | $4.30B | $4.83B | $3.71B | $4.99B | $5.41B | $4.97B | $4.04B | $5.13B |
| Capital expenditure | $993.0M | $925.0M | $859.0M | $996.0M | $1.20B | $1.17B | $1.02B | $1.02B |
| Free cash flow | $3.31B | $3.90B | $2.85B | $3.99B | $4.21B | $3.81B | $3.03B | $4.11B |
| Dividends paid | $2.44B | $2.44B | $2.43B | $2.55B | $2.55B | $2.54B | $2.53B | $2.61B |
| Share buybacks | $1.94B | $2.51B | $1.35B | $700.0M | $1.25B | $2.28B | $625.0M | $875.0M |
From Procter & Gamble's 10-K and 10-Q filings with the SEC; its fiscal year ends in June. Each period shows the latest figure the company has reported for it, including restatements. Net margin is our own calculation from those reported figures (net income ÷ revenue); it is left blank where revenue is zero or missing. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →
About Procter & Gamble
The Procter & Gamble Company (P&G) is an American multinational consumer goods corporation incorporated and headquartered in Cincinnati, Ohio. The company was founded in 1837 by William Procter and James Gamble.
Source: Wikipedia — Procter & Gamble
- Headquarters
- Cincinnati, Ohio From SEC filings, Oct 2026
Recent News (20)
-
A director receives 1,438 stock units at Procter & Gamble (PG), bringing his direct position to 7,768 shares. A director receives 1,438 stock units at Procter & Gamble (PG), bringing his direct position to 7,768 shares. Stock Titan
-
After acquiring 1,438 stock units, Procter & Gamble (PG) director Portman holds 6,685 common shares. After acquiring 1,438 stock units, Procter & Gamble (PG) director Portman holds 6,685 common shares. Stock Titan
-
-
Procter & Gamble (PG) awards Christine M. McCarthy 1,438 stock units; her direct holdings total 19,342 shares. Procter & Gamble (PG) awards Christine M. McCarthy 1,438 stock units; her direct holdings total 19,342 shares. Stock Titan
-
Director Christopher J. Kempczinski receives 1,438 stock units from Procter & Gamble (PG). Director Christopher J. Kempczinski receives 1,438 stock units from Procter & Gamble (PG). Stock Titan
-
-
-
-
Is Procter & Gamble Stock Priced Right Against Its Peers? Is Procter & Gamble Stock Priced Right Against Its Peers? Yahoo Finance
-
-
-
-
-
-
-
P&G (PG) Trades Below Its Historical Average: Bargain or Value Trap? P&G (PG) Trades Below Its Historical Average: Bargain or Value Trap? Yahoo Finance
-
-
-
-
More Consumer Staples stocks
- MKC McCormick & Company
- MNST Monster Beverage
- MO Altria
- PEP PepsiCo
- PM Philip Morris International
- SJM J.M. Smucker Company (The)
- STZ Constellation Brands
- SYY Sysco